Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1
- PMID: 8610455
- DOI: 10.1006/viro.1996.0158
Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1
Abstract
Some neuronal-derived CD4-negative cells are susceptible to infection with human immunodeficiency virus type 1 (HIV-1). Galactosyl ceramide is an alternate receptor for HIV-1 that appears to bind in vitro to the C2, V3, V4, and V5 regions of gp120. Amino acid variation in the V3 loop of HIV-1 affects cellular tropism in CD4-positive cells, but its effect on CD4-negative cells has not been fully analyzed. Here, we describe the effect of amino acid changes in V3 on the HIV-1 infection of a CD4-negative neuronal cell line, SK-N-MC. The sequence of the V3 domain was found to dramatically alter virus infectivity. Furthermore, a gp120 V3 loop neutralizing monoclonal antibody blocked HIV-1 infection of SK-N-MC cells. This data suggests that V3 may also serve as a primary viral determinant for infectivity of CD4-negative cells.
Similar articles
-
Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1.Virology. 1995 Jul 10;210(2):490-4. doi: 10.1006/viro.1995.1367. Virology. 1995. PMID: 7618285
-
SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.Biochemistry. 1996 Dec 10;35(49):15663-71. doi: 10.1021/bi961205g. Biochemistry. 1996. PMID: 8961929
-
The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.Immunology. 1995 Jun;85(2):176-83. Immunology. 1995. PMID: 7642208 Free PMC article.
-
Receptor-mediated activation of the viral envelope and viral entry.AIDS. 1993;7 Suppl 1:S43-50. AIDS. 1993. PMID: 8363802 Review. No abstract available.
-
Viral determinants of cellular tropism.Pathobiology. 1992;60(4):225-33. doi: 10.1159/000163727. Pathobiology. 1992. PMID: 1388720 Review.
Cited by
-
trans-dominant interference with human immunodeficiency virus type 1 replication and transmission in CD4(+) cells by an envelope double mutant.J Virol. 1999 Oct;73(10):8290-302. doi: 10.1128/JVI.73.10.8290-8302.1999. J Virol. 1999. PMID: 10482579 Free PMC article.
-
Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.J Virol. 2005 Jul;79(13):8374-87. doi: 10.1128/JVI.79.13.8374-8387.2005. J Virol. 2005. PMID: 15956582 Free PMC article.
-
Lack of association of HIV-1 biological or molecular properties with neurotropism for brain cells.J Mol Neurosci. 2006;29(2):131-44. doi: 10.1385/JMN:29:2:131. J Mol Neurosci. 2006. PMID: 16954603
-
Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1.Virology. 2011 Jan 20;409(2):308-18. doi: 10.1016/j.virol.2010.09.026. Epub 2010 Nov 10. Virology. 2011. PMID: 21071054 Free PMC article.
-
Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.J Virol. 2001 Sep;75(18):8605-14. doi: 10.1128/jvi.75.18.8605-8614.2001. J Virol. 2001. PMID: 11507206 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
